Rigel Pharmaceuticals Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$58,818	$69,802	$69,462	$101,685
Gross Profit	54,212	63,847	64,709	97,181
EBITDA	13,687	25,014	30,117	62,463
EBIT	13,090	24,413	29,514	61,856
Net Income	8,654	268,065	27,900	59,613
Net Change In Cash	58,818	69,802	69,462	101,685
Free Cash Flow	2,725	21,992	24,019	30,537
Cash	24,411	40,580	48,534	53,407
Basic Shares	19,686	18,840	19,156	18,162

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$294,282	$179,278	$116,882	$120,242
Gross Profit	274,661	160,631	109,772	118,493
EBITDA	131,562	28,512	-16,981	-53,868
EBIT	129,147	26,284	-18,219	-54,866
Net Income	367,024	17,485	-25,091	-58,573
Net Change In Cash	294,282	179,278	116,882	120,242
Cost of Revenue				5,569
Free Cash Flow	75,655	31,075	-20,743	-74,208
Cash	40,580	56,746	32,786	24,459
Basic Shares	18,840	17,687	17,401	17,240